NCT02570633

Ginger Capsules for the Prophylactic Treatment of Migraine

Double-blind Placebo-controlled Clinical Trial of Ginger (Zingiber Officinale) in Prophylactic Migraine Treatment

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 107 (actual)
• Sponsor: Federal University of Minas Gerais · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The main objective of the study is to evaluate ginger efficacy as an prophylactic treatment of migraine.

Detailed description

Patients with the diagnosis of migraine according to the IHS criteria will receive capsules of 200 mg of ginger extract (5% active ingredient) or placebo (cellulose) to be taken three times a day for 12 weeks.

Conditions

• Migraine

Interventions

Type	Name	Description
OTHER	Extract of ginger	Migraine patients (both genders) will receive capsules of 200 mg of ginger extract (5% gingerols) to be taken three times a day for 12 weeks.
OTHER	Cellulose	Migraine patients (both genders) will receive capsules of 200 mg of placebo (cellulose) to be taken three times a day for 12 weeks.

Timeline

• Start date: 2015-04-01
• Primary completion: 2016-07-01
• Completion: 2016-11-01
• First posted: 2015-10-07
• Last updated: 2020-03-16

Locations

1 site across 1 country: Brazil